Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 886982 NEW YORK, NY
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$839,560
+$649,360 QoQ
Shares Held
80,572
+160.5% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 95 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. RNAC ranks #266 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in RNAC

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $839,560 80,572
2026-03-31 $190,200 30,927
2025-03-31 $207,914 15,775
2024-12-31 $492,972 27,525
2024-09-30 $182,736 11,336
2024-03-31 $767,027 1,180,043
2023-12-31 $1,024,542 1,487,000
2023-09-30 $1,418,564 1,338,269
2023-06-30 $1,580,182 1,410,878
2023-03-31 $536,141 385,714
2022-12-31 $88,298 78,140
2022-09-30 $246,045 150,028
2022-06-30 $344,091 262,666
2022-03-31 $1,425,885 1,159,257
2021-12-31 $3,997,740 1,226,301
2021-09-30 $5,392,765 1,296,338
2021-06-30 $6,747,886 1,614,327
2021-03-31 $9,620,778 2,126,139
2020-12-31 $1,789,462 590,582
2020-09-30 $487,373 196,522
2020-06-30 $160,394 56,477
2020-03-31 $229,730 95,324